Sohlenius-Sternbeck Anna-Karin, Fagerholm Urban, Bylund Johan
DMPK, CNSP iMed, AstraZeneca R&D Södertälje, SE-151 85 Södertälje, Sweden.
Xenobiotica. 2013 Aug;43(8):671-8. doi: 10.3109/00498254.2012.755578. Epub 2013 Jan 16.
Abstract 1. We applied the regression offset approach to predict rat in vivo intrinsic clearance (CLint) for 54 new chemical acid entities with high plasma protein binding values and low renal clearance (CL). The prediction success was correlated to volume of distribution (Vd), molecular weight (Mw) and CL. 2. A correlation between poor in vitro-in vivo extrapolation (IVIVE) and Vd values distinct from the Vd of albumin (0.1-0.2 L/kg) was revealed. For compounds with a Vd value above 0.5 L/kg, 0% of the predictions of in vivo CLint was within twofold of the observed value, compared to 69% for compounds with a Vd value below 0.5 L/kg. 3. Compounds with a Mw below 450 g/mol demonstrated more accurate in vivo CLint predictions than compounds with a Mw above 450 g/mol, i.e. 63% compared to 21% within twofold. For compounds with in vivo CL below 30% of the liver blood flow (LBF), 53% of the predictions was within twofold of the observed value, compared to 0% for compounds with CL above 30% of the LBF. 4. We show that accurate IVIVE for acidic compounds with high plasma protein binding and low renal CL can be associated with a low Vd (i.e. around the Vd of albumin) and with a low in vivo CL, and that Mw is an important optimization parameter for pharmacokinetic. This study also further demonstrates the advantages of the application of the regression method for identifying cases when metabolic CL is not the single major elimination pathway.
摘要 1. 我们应用回归偏移方法预测了54种具有高血浆蛋白结合值和低肾清除率(CL)的新型化学酸性实体的大鼠体内固有清除率(CLint)。预测成功率与分布容积(Vd)、分子量(Mw)和CL相关。2. 揭示了体外-体内外推(IVIVE)不佳与不同于白蛋白Vd(0.1 - 0.2 L/kg)的Vd值之间的相关性。对于Vd值高于0.5 L/kg的化合物,体内CLint预测值在观测值两倍范围内的比例为0%,而Vd值低于0.5 L/kg的化合物这一比例为69%。3. 分子量低于450 g/mol的化合物在体内CLint预测方面比分子量高于450 g/mol的化合物更准确,即在两倍范围内分别为63%和21%。对于体内CL低于肝血流量(LBF)30%的化合物,53%的预测值在观测值两倍范围内,而CL高于LBF 30%的化合物这一比例为0%。4. 我们表明,对于具有高血浆蛋白结合和低肾CL的酸性化合物,准确的IVIVE可能与低Vd(即接近白蛋白的Vd)和低体内CL相关,并且Mw是药代动力学的一个重要优化参数。本研究还进一步证明了应用回归方法在确定代谢CL不是单一主要消除途径的情况下的优势。